actinium-225
Commercial- Indications
- Cancer
Company intelligence / Profile preview
TRIUMF Innovations serves as the business interface and commercialization arm of TRIUMF, Canada’s national particle accelerator laboratory. It identifies, develops, incubates, and brings to market advanced technologies—especially in medical isotopes/radiopharmaceuticals—through partnerships with industry, academia, and government. The company has enabled at least five successful spin-off companies with more in the pipeline. Its activities span intellectual property management, fundraising support for startups emerging from TRIUMF research programs, licensing deals with industry partners worldwide, irradiation testing services for electronics/devices used in harsh environments like space or nuclear facilities—and entrepreneurship training programs for scientists.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TRIUMF Innovations.